Multiple health care industries have shown support for an expansion of a tax credit for research and development and efforts to make it permanent. "For America to keep its global leadership in medical innovation, it is critical that public policies and programs support continued research and development ... of new medicines," according to the Pharmaceutical Research and Manufacturers of America, which has not formally thrown its support behind Obama's specific proposal.

Full Story:
Hill, The

Related Summaries